We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-12.71%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$326M
AUM Growth
+$190M
Cap. Flow
+$241M
Cap. Flow %
73.95%
Top 10 Hldgs %
96.62%
Holding
33
New
4
Increased
7
Reduced
9
Closed
10

Top Buys

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$1.48M
2
MNKD icon
MannKind Corp
MNKD
+$1.35M
3
WGS icon
GeneDx Holdings
WGS
+$705K
4
BHVN icon
Biohaven
BHVN
+$203K
5
ARDX icon
Ardelyx
ARDX
+$195K

Top Sells

Rank Stock Value
1
OPK icon
Opko Health
OPK
+$6.91M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$5.51M
3
QDEL icon
QuidelOrtho
QDEL
+$4.33M
4
PACB icon
Pacific Biosciences
PACB
+$4.31M
5
BPMC
Blueprint Medicines
BPMC
+$2.62M

Sector Composition

Rank Sector Weight
1 Healthcare 19.94%
2 Energy 0.03%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
CALL
QuidelOrtho
QDEL
$1.14B
$137M 41.92%
1,870,000
+1,787,800
+2,175% +$143M
PACB icon
2
CALL
Pacific Biosciences
PACB
$432M
$75.9M 23.3%
9,093,000
+8,577,900
+1,665% +$98M
BHVN icon
3
CALL
Biohaven
BHVN
$2.07B
$40.9M 12.56%
1,573,000
+1,524,400
+3,137% +$31.7M
BHVN icon
4
Biohaven
BHVN
$2.07B
$15.8M 4.85%
607,527
+9,754
+2% +$203K
QDEL icon
5
QuidelOrtho
QDEL
$1.14B
$14M 4.29%
191,244
-54,251
-22% -$4.33M
PACB icon
6
Pacific Biosciences
PACB
$432M
$13.7M 4.2%
1,638,395
-377,100
-19% -$4.31M
QDEL icon
7
PUT
QuidelOrtho
QDEL
$1.14B
$7.3M 2.24%
+100,000
New +$7.99M
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.48B
$3.93M 1.21%
555,522
– –
WGS icon
9
GeneDx Holdings
WGS
$1.84B
$3.62M 1.11%
994,580
+128,731
+15% +$705K
ARDX icon
10
Ardelyx
ARDX
$1.25B
$3.06M 0.94%
749,700
+50,000
+7% +$195K
FORA
11
DELISTED
Forian
FORA
$3.05M 0.94%
1,368,067
+3,738
+0.3% +$9.29K
AGEN
12
Agenus
AGEN
$275M
$2.39M 0.73%
105,848
-46,975
-31% -$1.33M
MNKD icon
13
MannKind Corp
MNKD
$1.21B
$1.24M 0.38%
+300,000
New +$1.35M
IMMP
14
Immutep
IMMP
$57M
$981K 0.3%
516,430
-377,961
-42% -$767K
NSTG
15
DELISTED
NanoString Technologies, Inc.
NSTG
$836K 0.26%
+485,886
New +$1.48M
AXDX
16
DELISTED
Accelerate Diagnostics
AXDX
$785K 0.24%
136,528
-14,537
-10% -$97.8K
OPK icon
17
Opko Health
OPK
$1.25B
$721K 0.22%
450,564
-3,791,901
-89% -$6.91M
BIIB icon
18
Biogen
BIIB
$30.4B
$620K 0.19%
2,412
– –
VTNR
19
DELISTED
Vertex Energy, Inc
VTNR
$113K 0.03%
25,300
-75,100
-75% -$386K
OMGA
20
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$108K 0.03%
50,000
-147,449
-75% -$589K
BDSX icon
21
Biodesix
BDSX
$218M
$69.4K 0.02%
+2,104
New +$58.4K
DMTK
22
DELISTED
DermTech, Inc. Common Stock
DMTK
$68.7K 0.02%
47,687
– –
INKT icon
23
MiNK Therapeutics
INKT
$52.5M
$40.6K 0.01%
3,690
-1,356
-27% -$22.1K
BPMC
24
CALL
DELISTED
Blueprint Medicines
BPMC
– –
-64,500
Closed -$4.08M
BPMC
25
DELISTED
Blueprint Medicines
BPMC
– –
-41,377
Closed -$2.62M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Oracle Investment Management held 33 positions worth $326M, up 140% from $136M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Oracle Investment Management deployed $241M of net new capital in Q3 2023, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 485,886 shares worth $836K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 77% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Opko Health, an estimated $6.91M trimmed.

  • Oracle Investment Management's largest Q3 2023 buy was NanoString Technologies, Inc.: 485,886 shares worth $836K.
  • Oracle Investment Management added most to GeneDx Holdings in Q3 2023, an estimated $705K increase.
  • Oracle Investment Management's biggest Q3 2023 reduction was Opko Health, cutting an estimated $6.91M.
  • Oracle Investment Management fully exited Mirati Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $5.51M.
  • Oracle Investment Management's ten largest holdings make up 97% of its $326M portfolio in Q3 2023.
  • Oracle Investment Management opened 4 new positions and closed 10 in Q3 2023.
  • Oracle Investment Management's portfolio value rose 140% quarter-over-quarter to $326M.

Based on Oracle Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.